ASCO 2023

ASCO 2023

At ASCO this year, we will share new data from our robust portfolio and pipeline of advanced therapeutic platforms in cancer and blood disorders, showcasing the impact of our bold science in research.

Media releases

3D Illustration of molecules

ASCO for HCPs

Novartis continues to pursue scientific breakthroughs with the ambition to transform lives and renew patients’ hopes for the future.

Scientists working in the lab at night

Investor Event

June 04, 2023 | Chicago, USA

Watch the webcast
Download the presentation (PDF 1.2 MB)

Scientist working in a lab with frozen elements

Progress and Optimism in Oncology Today

Vas Narasimhan, CEO of Novartis

Read Vas article on LinkedIn

Related topics

Cancer

At Novartis, we’re committed to unraveling the inner workings of cancer. We’re developing new therapies for a range of common and rare cancers, investing in diverse technology platforms and experimenting with combination approaches.

Therapeutic areas

At Novartis, we invest in the most promising frontiers of science, the most exciting innovations in the business of medicine, and the most significant healthcare needs.

Source URL: https://www.novartis.com/healthcare-professionals/medical-congresses-and-events/asco-annual-meeting/asco-2023

List of links present in page

https://www.novartis.com/healthcare-professionals/medical-congresses-and-events/asco-annual-meeting/asco-2023
https://www.novartis.com/news/news-archive?type=media_release
https://www.hcp.novartis.com/virtual-congress/a-2023/
https://edge.media-server.com/mmc/p/uzcyixj2
https://www.novartis.com/sites/novartis_com/files/2023-06-novartis-asco-presentation.pdf
https://www.novartis.com/investors/event-calendar
https://www.linkedin.com/pulse/progress-optimism-oncology-today-vas-narasimhan?utm_source=share&utm_medium=member_ios&utm_campaign=share_via
https://www.novartis.com/about/therapeutic-areas/solid-tumors
https://www.novartis.com/about/therapeutic-areas